Hurthle Cell Lesion: Controversies, Challenges, and Debates
- PMID: 27186039
- PMCID: PMC4848220
- DOI: 10.1007/s12262-015-1381-x
Hurthle Cell Lesion: Controversies, Challenges, and Debates
Abstract
Hurthle cell lesion is one of the most questionable clinico-pathological entities in most of its aspects. Literature has used the terms oncocytic, oxyphilic, Hurthle, and Ashkanazy interchangeably; what does each term denote? Who first described these cells? What is the cell of origin? How much Hurthle cells should be present to define the lesion as Hurthle cell one? Is it possible to differentiate hyperplastic from neoplastic and benign from malignant Hurthle cell lesion on a non-histopathologic ground? Does it belong to follicular or to papillary neoplasms or should it be classified separately? Can we anticipate its clinical behavior or predict its outcome? How can we manage? We will try to answer these questions in light of the ongoing relevant arguments with the aim of resolving some uncertainties and suggesting how to solve others.
Keywords: Hurthle; Oncocytic; Oxyphilic; Thyroid.
References
-
- Prabakaran SS, Chen F, Aguirre A. Oncocytoma of the parotid gland and its mimickers: a comprehensive review. N Am J Med Sci. 2010;3:171–180. doi: 10.7156/v3i4p171. - DOI
-
- Hurthle K. BeitrÃgezurKenntniss des Secretionsvorgangs in der. SchilddrÃse. Pflugers Arch Physiol. 1894;56:10–44. doi: 10.1007/BF01662011. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources